 CAMBRIDGE, Mass., Sept. 13, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. Nasdaq: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Jennifer Herron, Senior Vice President Chief Commercial Officer at ADC Therapeutics SA ADCT, has joined its board of directors. 